medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2012, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2012; 10 (2)

Mycotic paronychia due to Fusarium solani: Case report and review

de la Herrán P, López LH, Fierro-Arias L, Ponce ORM, Hernández MA, Bonifaz A

Language: Spanish
References: 16
Page: 139-142
PDF size: 120.86 Kb.


ABSTRACT

Onychomycosis is the most common nail pathology. The main etiologic agents are dermatophytes, yeasts and molds. The prevalence of Fusarium spp., a non dermatophyte mold in onychomycosis has increased in recent years, from 0.97% up to 7.8%. These findings are variable depending on the affected nails, geographic factors, and patient’s medical history. The fingernails involvement is very exceptional, varying from 0% to 5.5%. We present a 68 year-old diabetic female, with a total dystrophic fingernail onychomycosis, caused by Fusarium spp. We reviewed the available literature.


REFERENCES

  1. Guilhermetti E, Takahachi G, Shinobu CS, Estivalet ST. “Fusarium spp. as agents of onychomycosis in immunocompetent hosts”. Int J Dermatol 2007; 46: 822-826.

  2. Mousavi SA, Esfandiarpour I, Salari S, Shokri H. “Onychomycosis due to Fusarium spp. In patient with squamous cell carcinoma: A case report from Kerman, Iran”. J Micol Med 2009; 19: 146-149.

  3. Bonifaz A, Cruz AP, Ponce RM. “Onychomycosis by molds: Report of 78 cases”. Eur J Dermatol 2006; 17: 1-3.

  4. Gianni C, Cerri A, Crosti C. “Case report: Unusual clinical features of fingernail infection by Fusarium oxysporum”. Mycoses 1997; 40: 455-459

  5. Souza LK, Fernández OF, Passos XS, Costa CR, Lemos JA, Silva MR. “Epidemiological and mycological data of onychomycosis in Goiania, Brazil”. Mycoses 2010; 53: 68-71.

  6. Moreno G, Arenas R. “Other fungi causing onychomycosis”. Clin Dermatol 2010; 28: 160-163.

  7. Zuluaga de CA, Bedout C, Tabares A, Cano L, Restrepo A, Arango M, et al. “Behavior of etiologic agents of onychomycosis in a mycology reference laboratory (Medellin 1994-2003)”. Med Cutan Iber Lat Am 2005; 33: 251-256.

  8. non-dermatophyte onychomycosis in Singapore”. Australas J Dermatol 1992; 33: 159-163.

  9. Liarán R, Tosti A, Piraccini BM. “Uncommon clinical patterns of Fusarium sp nail infection: report of three cases”. Br J Dermatol 1997; 136: 424-427.

  10. López CN, Casas C, Sopo L, Rojas A, Del Portillo P, Cepero de García MC, et al. “Fusarium species detected in onychomycosis in Colombia”. Mycoses 2008; 52: 350-356.

  11. Gupta AK, Jain HC, Lynde CW, MacDonald P, Cooper EA, Summerbell RC. “Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: a multicenter Canadian survey of 15 000 patients”. J Am Acad Dermatol 2000; 43: 244-248.

  12. Baran R, Tosti A, Piraccini BM. “Uncommon clinical patterns of Fusarium nail infection: report of three cases”. Br J Dermatol 1997; 136: 424-427.

  13. Alborch L, Bragulat MR, Cabañes FJ. “Comparison of two selective culture media for the detection of Fusarium infection in conventional and transgenic maize kernels”. Lett App Microbiology 2010; 50: 270-275.

  14. Escobar LM, Carmona FJ. “Onicomicosis por hongos ambientales no dermatofitos”. Rev Iberoam Micol 2003; 20: 6-10.

  15. Ballesté R, Mousqués N, Gezuele E. “Onicomicosis: una revisión”. Rev Med Uruguay 2003; 19: 93-106.

  16. Baudraz-Rosselet F, Ruffieux C, Lurati M, Bontems O, Monod M. “Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents”. Dermatology 2010; 220: 164-168.




2020     |     www.medigraphic.com